265 related items for PubMed ID: 16126052
1. Comparative efficacy and safety of low-dose fluticasone propionate and montelukast in children with persistent asthma.
Ostrom NK, Decotiis BA, Lincourt WR, Edwards LD, Hanson KM, Carranza Rosenzweig JR, Crim C.
J Pediatr; 2005 Aug; 147(2):213-20. PubMed ID: 16126052
[Abstract] [Full Text] [Related]
2. Efficacy and tolerability of salmeterol/fluticasone propionate versus montelukast in childhood asthma: A prospective, randomized, double-blind, double-dummy, parallel-group study.
Maspero J, Guerra F, Cuevas F, Gutierrez JP, Soto-Ramos M, Anderton S, Mechali D, Chan R, Pedersen S.
Clin Ther; 2008 Aug; 30(8):1492-504. PubMed ID: 18803991
[Abstract] [Full Text] [Related]
3. Low-dose fluticasone propionate compared with montelukast for first-line treatment of persistent asthma: a randomized clinical trial.
Busse W, Raphael GD, Galant S, Kalberg C, Goode-Sellers S, Srebro S, Edwards L, Rickard K, Fluticasone Proprionate Clinical Research Study Group.
J Allergy Clin Immunol; 2001 Mar; 107(3):461-8. PubMed ID: 11240946
[Abstract] [Full Text] [Related]
4. Comparative efficacy and cost of asthma care in children with asthma treated with fluticasone propionate and montelukast.
Stempel DA, Kruzikas DT, Manjunath R.
J Pediatr; 2007 Feb; 150(2):162-7. PubMed ID: 17236894
[Abstract] [Full Text] [Related]
5. Diskus and diskhaler: efficacy and safety of fluticasone propionate via two dry powder inhalers in subjects with mild-to-moderate persistent asthma.
Galant SP, van Bavel J, Finn A, Gross G, Pleskow W, Brown A, Hamedani AG, Harding SM.
Ann Allergy Asthma Immunol; 1999 Mar; 82(3):273-80. PubMed ID: 10094218
[Abstract] [Full Text] [Related]
6. Tolerability of a salmeterol xinafoate/fluticasone propionate hydrofluoroalkane metered-dose inhaler in adolescent and adult patients with persistent asthma: a 52-week, open-label, stratified, parallel-group, multicenter study.
Cowie RL, Boulet LP, Keith PK, Scott-Wilson CA, House KW, Dorinsky PM.
Clin Ther; 2007 Jul; 29(7):1390-402. PubMed ID: 17825690
[Abstract] [Full Text] [Related]
7. Fluticasone propionate/salmeterol combination provides more effective asthma control than low-dose inhaled corticosteroid plus montelukast.
Nelson HS, Busse WW, Kerwin E, Church N, Emmett A, Rickard K, Knobil K.
J Allergy Clin Immunol; 2000 Dec; 106(6):1088-95. PubMed ID: 11112891
[Abstract] [Full Text] [Related]
8. Adherence to asthma controller medication regimens.
Stempel DA, Stoloff SW, Carranza Rosenzweig JR, Stanford RH, Ryskina KL, Legorreta AP.
Respir Med; 2005 Oct; 99(10):1263-7. PubMed ID: 16140227
[Abstract] [Full Text] [Related]
9. Initiation of maintenance therapy with salmeterol/fluticasone propionate combination therapy in moderate asthma: a comparison with fluticasone propionate.
Rojas RA, Paluga I, Goldfrad CH, Duggan MT, Barnes N.
J Asthma; 2007 Oct; 44(6):437-41. PubMed ID: 17654129
[Abstract] [Full Text] [Related]
10. Efficacy and safety of dry powder fluticasone propionate in children with persistent asthma.
LaForce CF, Pearlman DS, Ruff ME, Silvers WS, Weinstein SW, Clements DS, Brown A, Duke S, Harding SM, House KW.
Ann Allergy Asthma Immunol; 2000 Nov; 85(5):407-15. PubMed ID: 11101186
[Abstract] [Full Text] [Related]
11. Fluticasone propionate/salmeterol combination compared with montelukast for the treatment of persistent asthma.
Pearlman DS, White MV, Lieberman AK, Pepsin PJ, Kalberg C, Emmett A, Bowers B, Rickard KA, Dorinsky P.
Ann Allergy Asthma Immunol; 2002 Feb; 88(2):227-35. PubMed ID: 11868930
[Abstract] [Full Text] [Related]
12. Cost effectiveness of fluticasone propionate plus salmeterol versus fluticasone propionate plus montelukast in the treatment of persistent asthma.
O'Connor RD, Nelson H, Borker R, Emmett A, Jhingran P, Rickard K, Dorinsky P.
Pharmacoeconomics; 2004 Feb; 22(12):815-25. PubMed ID: 15294013
[Abstract] [Full Text] [Related]
13. Comparison of asthma costs in patients starting fluticasone propionate compared to patients starting montelukast.
Stempel DA, Mauskopf J, McLaughlin T, Yazdani C, Stanford RH.
Respir Med; 2001 Mar; 95(3):227-34. PubMed ID: 11266241
[Abstract] [Full Text] [Related]
14. Efficacy and tolerability of salmeterol/fluticasone propionate versus fluticasone propionate in asthma patients: a randomized, double-blind study.
Lee YS, Lin HC, Huang CD, Lee KY, Liu CY, Yu CT, Wang CH, Kuo HP.
Chang Gung Med J; 2011 Mar; 34(4):382-94. PubMed ID: 21880193
[Abstract] [Full Text] [Related]
15. Efficacy and safety profile of fluticasone furoate administered once daily in the morning or evening: a randomized, double-blind, double-dummy, placebo-controlled trial in adult and adolescent patients with persistent bronchial asthma.
Medley H, Orozco S, Allen A.
Clin Ther; 2012 Aug; 34(8):1683-95. PubMed ID: 22796247
[Abstract] [Full Text] [Related]
16. Comparing outcomes in patients with persistent asthma: a registry of two therapeutic alternatives.
O'Connor RD, Gilmore AS, Manjunath R, Stanford RH, Legorreta AP, Jhingran PM.
Curr Med Res Opin; 2006 Mar; 22(3):453-61. PubMed ID: 16574029
[Abstract] [Full Text] [Related]
17. Low-dose fluticasone propionate with and without salmeterol in steroid-naïve patients with mild, uncontrolled asthma.
Renzi PM, Howard LA, Ortega HG, Ahmad FF, Chapman KR.
Respir Med; 2010 Apr; 104(4):510-7. PubMed ID: 19944581
[Abstract] [Full Text] [Related]
18. Efficacy and safety of inhaled fluticasone propionate chlorofluorocarbon in 2- to 4-year-old patients with asthma: results of a double-blind, placebo-controlled study.
Wasserman RL, Baker JW, Kim KT, Blake KV, Scott CA, Wu W, Faris MA, Crim C.
Ann Allergy Asthma Immunol; 2006 Jun; 96(6):808-18. PubMed ID: 16802768
[Abstract] [Full Text] [Related]
19. Long-term comparison of 3 controller regimens for mild-moderate persistent childhood asthma: the Pediatric Asthma Controller Trial.
Sorkness CA, Lemanske RF, Mauger DT, Boehmer SJ, Chinchilli VM, Martinez FD, Strunk RC, Szefler SJ, Zeiger RS, Bacharier LB, Bloomberg GR, Covar RA, Guilbert TW, Heldt G, Larsen G, Mellon MH, Morgan WJ, Moss MH, Spahn JD, Taussig LM, Childhood Asthma Research and Education Network of the National Heart, Lung, and Blood Institute.
J Allergy Clin Immunol; 2007 Jan; 119(1):64-72. PubMed ID: 17140647
[Abstract] [Full Text] [Related]
20. Short-term and long-term asthma control in patients with mild persistent asthma receiving montelukast or fluticasone: a randomized controlled trial.
Zeiger RS, Bird SR, Kaplan MS, Schatz M, Pearlman DS, Orav EJ, Hustad CM, Edelman JM.
Am J Med; 2005 Jun; 118(6):649-57. PubMed ID: 15922697
[Abstract] [Full Text] [Related]
Page: [Next] [New Search]
